Should every study have planned secondary and exploratory objectives?
Designing a clinical or observational study is a process that goes far beyond defining the main research question. While the primary objective remains the foundation of any research project, secondary and exploratory objectives are playing an increasingly important role in modern studies. This raises the question: should every study include them? The answer is not straightforward – but in practice, well-planned additional objectives often determine the real scientific and business value of a project.
The primary objective defines the basic research hypothesis and determines the structure of the protocol, sample size, and statistical analysis plan. It is on this basis that regulators, sponsors, and the scientific community assess the efficacy and/or safety of the investigated medicinal product/medical device. However, limiting the project to just one endpoint may lead to the loss of valuable information that is also available in the collected data.
Secondary objectives allow for an expanded perspective in the analysis – they may concern additional aspects of efficacy, safety profile, quality of life, patient adherence, or differences between subgroups. Exploratory objectives, on the other hand, enable the identification of new relationships, generation of hypotheses for future studies, and better understanding of the mechanisms of therapy.
Why are secondary objectives the standard today? In practice, most clinical trials include secondary objectives because they increase the scientific value of the project without the need to conduct a new study, enable fuller utilization of collected data, support future regulatory and reimbursement strategies, provide material for scientific publications and medical communication, and help prepare for subsequent phases of product development. Well-planned secondary objectives also help sponsors answer stakeholder questions that often arise only after the study is completed – e.g., regarding efficacy in specific patient populations.
Exploratory objectives may be seen as optional, but in reality, they are one of the most important tools for developing innovations. It is often exploratory analyses that lead to the discovery of new therapeutic indications, biomarkers, or optimal treatment regimens. However, their proper planning is key. A lack of a clearly defined analytical strategy can lead to overinterpretation of results or problems during publication and regulatory assessment. Therefore, exploratory objectives should always be logically linked to the primary objective and appropriately described in the protocol and Statistical Analysis Plan.
Does every study need them? Not every study requires an extensive set of additional objectives – particularly pilot projects or studies with a very narrow scope may focus solely on the primary objective. However, in most cases, the absence of secondary and exploratory objectives means untapped data potential and limited future analytical possibilities. The best approach is an individual assessment of the project, considering the product development stage, regulator expectations, publication strategy, and the sponsor's business goals.
Experience shows that the biggest challenge is not simply adding additional objectives but designing them properly – so they are methodologically justified, statistically feasible, and simultaneously useful from a business perspective. This requires close cooperation between medical, biostatistical, and regulatory teams at the study concept stage.
At this stage, the support of an experienced CRO partner can significantly reduce the risk of costly protocol changes in later phases of the project. Biostat experts assist sponsors in defining the optimal structure of endpoints, designing statistical analysis plans, and ensuring compliance with current regulatory guidelines and good clinical practice.
Are you planning a clinical or observational study and want to ensure its full analytical potential is utilized? Contact the Biostat team – we will help design a study that delivers not only the required results but also real scientific and business advantages.
